Watch him lower to $250 because this is "break even", but still way above the $13 it was before.
Turing to roll back pricing for Daraprim amid controversy
The pharmaceutical company boss under fire from Hillary Clinton and many others for jacking up the price of the drug Daraprim 5,000 percent overnight said Tuesday he will lower the cost of the life-saving drug.
Martin Shkreli did not say what the new price would be but expected a determination to be made over the next few weeks.
He told NBC News that the decision to lower the price was a reaction to outrage over the increase in the price of the drug from $13.50 to $750 per pill.
"Yes it is absolutely a reaction — there were mistakes made with respect to helping people understand why we took this action, I think that it makes sense to lower the price in response to the anger that was felt by people," Shkreli said, 32.
Turing Pharmaceuticals of New York bought the drug from Impax Laboratories in August for $55 million and raised the price. Shkreli said the price would return to $13.50 in a few weeks.
Submitted September 23, 2015 at 09:01AM by StockJock-e http://ift.tt/1L5LD7u
No comments:
Post a Comment